carcinoma in situ造句
1. Lobular carcinoma in situ is seen here.
2. Normal breast with non – invasive ductal carcinoma in situ ( DCIS ) in an enlarged crosssection of the duct.
3. Sentinel lymph node biopsy is indicated for ductal carcinoma in situ, with prophylactic mastectomy, breast cancer patients with previous reduction mammoplasty and breast implants.
4. Treatment of ductal carcinoma in situ . [ comment ] .
5. Normal breast with lobular carcinoma in situ ( LCIS ) in an enlarged cross – section of the lobule.
6. Intravesical treatment is used for carcinoma in situ and other high grade non - muscle - invasive tumours.
7. The patient treated for carcinoma in situ of the cervix must receive adequate follow - up.
8. Screening picks up more cases of ductal carcinoma in situ (DCIS) - cancer in cells lining the milk ducts that has not spread - than would normally be found because it is often symptomless.
9. The other 3 cases were carcinoma in situ or intraductal carcinoma of breast.
10. These lesions included ductal carcinoma in situ ( DCIS ), invasive lobular cancer, cysts, and fibroadenomas.
11. Objective To summarize the experience of diagnosis and treatment of breast carcinoma in situ ( CLS ).
12. Objective To study radiologic ( molybdenum target X - ray ) findings of ductal carcinoma in situ ( DCIS ) of breast.
13. Objective To study the roles and mechanisms of Isatis tinctoriaL combination acid in transplanted tumor of human hepatocellular carcinoma in situ.
14. Bowenoid papulosis consists of rough papular eruptions attributed to HPV and is considered to be a carcinoma in situ.
15. The true incidence of vaginal intraepithelial neoplasia is unknown, but rates of vulval carcinoma in situ have been rising and increased more than 400% in the United States between 1973 and 2000.
16. Methods Retrospectively investigated clinical and experiment data in 8 patients with carcinoma in situ of liver transp, lantation.
17. At present, photodynamic therapy has been used in diagnosing and treating lower genital tract carcinoma in situ, and advanced malignant tumor such as vulval and ovarian carcinoma.
18. Objective To evaluate the ro le of periductal microvessel density (MVD) in predicting the transformation from ductal carcinoma in situ (DCIS) to invasive carcinoma in breast.